Literature DB >> 18082566

Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function.

Wen-Ming Peng1, Chun-Feng Yu, Jean-Pierre Allam, Johannes Oldenburg, Thomas Bieber, Jochen Hoch, Anna-Maria Eis-Hübinger, Natalija Novak.   

Abstract

Recognition of nucleic acids by TLR9 expressed by human plasmacytoid dendritic cells (PDC) plays a key role in the defense against viral infections. Upon microbial pathogen stimulation, PDC secrete large amounts of type I interferon and arbitrate thereby both innate and adaptive immune mechanisms. Unmethylated CpG motifs, which are an integral part of bacterial or viral DNA, are used in vitro and in vivo to activate the TLR9 pathway, whereas inhibitory oligodeoxynucleotide (iODN) are capable of depressing TLR9 signaling. In this study we demonstrate that TTAGGG motifs containing iODN efficiently block the TLR9 signaling in terms of herpes simplex virus (HSV)-induced type I interferon production by PDC. However, iODN, as well as control ODN, still promote PDC maturation with upregulated expression of costimulatory molecules, major histocompatibility complex molecules, and other signs for PDC maturation. Furthermore, iODN and control ODN incubated PDC demonstrate increased T-cell stimulatory functions. Coculture experiments with autologous T cells indicate that iODN-treated PDC induce more CD4(+)CD25(+)Foxp3(+) T regulatory cells from naive CD4(+) T cells and preincubation of HSV-stimulated PDC with iODN upregulated T cells' IFN-gamma production. These data indicate that iODN, while blocking type I interferon production by PDC, modify PDC activation and maturation as well as T-cell priming and stimulation. Knowledge about the different functions of iODN on PDC elucidated might be crucial for immunotherapeutic strategies in which iODN motifs are used to prevent the interaction of CpG-DNA with TLR9 to calm down specific immunological responses, because our data indicate that iODN might not only have inhibitory functions but also be effective activators of immune cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18082566      PMCID: PMC2754864          DOI: 10.1016/j.humimm.2007.10.008

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  35 in total

1.  The nature of the principal type 1 interferon-producing cells in human blood.

Authors:  F P Siegal; N Kadowaki; M Shodell; P A Fitzgerald-Bocarsly; K Shah; S Ho; S Antonenko; Y J Liu
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

2.  Suppressive oligodeoxynucleotides inhibit Th1 differentiation by blocking IFN-gamma- and IL-12-mediated signaling.

Authors:  Hidekazu Shirota; Mayda Gursel; Dennis M Klinman
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

Review 3.  IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors.

Authors:  Yong-Jun Liu
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

Authors:  A M Krieg; T Wu; R Weeratna; S M Efler; L Love-Homan; L Yang; A K Yi; D Short; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.

Authors:  M Cella; D Jarrossay; F Facchetti; O Alebardi; H Nakajima; A Lanzavecchia; M Colonna
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

6.  Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.

Authors:  E Ashley Moseman; Xueqing Liang; Amanda J Dawson; Angela Panoskaltsis-Mortari; Arthur M Krieg; Yong-Jun Liu; Bruce R Blazar; Wei Chen
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

7.  Stimulation of natural interferon-alpha/beta-producing cells by Staphylococcus aureus.

Authors:  H Svensson; B Cederblad; M Lindahl; G Alm
Journal:  J Interferon Cytokine Res       Date:  1996-01       Impact factor: 2.607

8.  Characterization of FcepsilonRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis.

Authors:  Natalija Novak; Jean-Pierre Allam; Tobias Hagemann; Claudia Jenneck; Sylvia Laffer; Rudolf Valenta; Jarema Kochan; Thomas Bieber
Journal:  J Allergy Clin Immunol       Date:  2004-08       Impact factor: 10.793

9.  TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function.

Authors:  Anne Krug; Anthony R French; Winfried Barchet; Jens A A Fischer; Andrzej Dzionek; Jeanette T Pingel; Michael M Orihuela; Shizuo Akira; Wayne M Yokoyama; Marco Colonna
Journal:  Immunity       Date:  2004-07       Impact factor: 31.745

10.  Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation.

Authors:  Géraldine Schlecht; Sylvie Garcia; Nicolas Escriou; Antonio A Freitas; Claude Leclerc; Gilles Dadaglio
Journal:  Blood       Date:  2004-05-27       Impact factor: 22.113

View more
  4 in total

1.  Toxoplasma gondii Inactivates Human Plasmacytoid Dendritic Cells by Functional Mimicry of IL-10.

Authors:  Piotr L Pierog; Yanlin Zhao; Sukhwinder Singh; Jihong Dai; George S Yap; Patricia Fitzgerald-Bocarsly
Journal:  J Immunol       Date:  2017-11-27       Impact factor: 5.422

Review 2.  Adjuvanted Immunotherapy Approaches for Peanut Allergy.

Authors:  Brandi T Johnson-Weaver; Herman F Staats; A Wesley Burks; Michael D Kulis
Journal:  Front Immunol       Date:  2018-09-25       Impact factor: 7.561

3.  TLR-9 contributes to the antiviral innate immune sensing of rodent parvoviruses MVMp and H-1PV by normal human immune cells.

Authors:  Zahari Raykov; Svitlana P Grekova; Rita Hörlein; Barbara Leuchs; Thomas Giese; Nathalia A Giese; Jean Rommelaere; Rainer Zawatzky; Laurent Daeffler
Journal:  PLoS One       Date:  2013-01-29       Impact factor: 3.240

Review 4.  The Roles of Type I Interferon in Co-infections With Parasites and Viruses, Bacteria, or Other Parasites.

Authors:  Yuanlin Ma; Xin-Zhuan Su; Fangli Lu
Journal:  Front Immunol       Date:  2020-10-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.